55 found
Order:
Disambiguations
Jeffrey P. Kahn [35]Jeffrey Kahn [20]Jeffrey Paul Kahn [1]
  1.  98
    Public Health Ethics: Mapping the Terrain.James F. Childress, Ruth R. Faden, Ruth D. Gaare, Lawrence O. Gostin, Jeffrey Kahn, Richard J. Bonnie, Nancy E. Kass, Anna C. Mastroianni, Jonathan D. Moreno & Phillip Nieburg - 2002 - Journal of Law, Medicine and Ethics 30 (2):170-178.
    Public health ethics, like the field of public health it addresses, traditionally has focused more on practice and particular cases than on theory, with the result that some concepts, methods, and boundaries remain largely undefined. This paper attempts to provide a rough conceptual map of the terrain of public health ethics. We begin by briefly defining public health and identifying general features of the field that are particularly relevant for a discussion of public health ethics.Public health is primarily concerned with (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   149 citations  
  2.  62
    Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations.Susan M. Wolf, Frances P. Lawrenz, Charles A. Nelson, Jeffrey P. Kahn, Mildred K. Cho, Ellen Wright Clayton, Joel G. Fletcher, Michael K. Georgieff, Dale Hammerschmidt, Kathy Hudson, Judy Illes, Vivek Kapur, Moira A. Keane, Barbara A. Koenig, Bonnie S. LeRoy, Elizabeth G. McFarland, Jordan Paradise, Lisa S. Parker, Sharon F. Terry, Brian Van Ness & Benjamin S. Wilfond - 2008 - Journal of Law, Medicine and Ethics 36 (2):219-248.
    No consensus yet exists on how to handle incidental fnd-ings in human subjects research. Yet empirical studies document IFs in a wide range of research studies, where IFs are fndings beyond the aims of the study that are of potential health or reproductive importance to the individual research participant. This paper reports recommendations of a two-year project group funded by NIH to study how to manage IFs in genetic and genomic research, as well as imaging research. We conclude that researchers (...)
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   109 citations  
  3.  68
    Research Led by Participants: A New Social Contract for a New Kind of Research.Effy Vayena, Roger Brownsword, Sarah Jane Edwards, Bastian Greshake, Jeffrey P. Kahn, Navjoyt Ladher, Jonathan Montgomery, Daniel O'Connor, Onora O'Neill, Martin P. Richards, Annette Rid, Mark Sheehan, Paul Wicks & John Tasioulas - 2016 - Journal of Medical Ethics 42 (4):216-219.
    Direct download (12 more)  
     
    Export citation  
     
    Bookmark   12 citations  
  4.  21
    A Conceptual Model for the Translation of Bioethics Research and Scholarship.Debra J. H. Mathews, D. Micah Hester, Jeffrey Kahn, Amy McGuire, Ross McKinney, Keith Meador, Sean Philpott-Jones, Stuart Youngner & Benjamin S. Wilfond - 2016 - Hastings Center Report 46 (5):34-39.
    While the bioethics literature demonstrates that the field has spent substantial time and thought over the last four decades on the goals, methods, and desired outcomes for service and training in bioethics, there has been less progress defining the nature and goals of bioethics research and scholarship. This gap makes it difficult both to describe the breadth and depth of these areas of bioethics and, importantly, to gauge their success. However, the gap also presents us with an opportunity to define (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  5.  73
    Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field.Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel & Samuel Wickline - 2012 - Journal of Law, Medicine and Ethics 40 (4):716-750.
    Nanomedicine is yielding new and improved treatments and diagnostics for a range of diseases and disorders. Nanomedicine applications incorporate materials and components with nanoscale dimensions where novel physiochemical properties emerge as a result of size-dependent phenomena and high surface-to-mass ratio. Nanotherapeutics and in vivo nanodiagnostics are a subset of nanomedicine products that enter the human body. These include drugs, biological products, implantable medical devices, and combination products that are designed to function in the body in ways unachievable at larger scales. (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  6.  7
    The BRAIN Initiative and Neuroethics: Enabling and Enhancing Neuroscience Advances for Society.James Eberwine & Jeffrey Kahn - 2020 - American Journal of Bioethics Neuroscience 11 (3):135-139.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  7. Sunset on the RAC: When Is It Time to End Special Oversight of an Emerging Biotechnology?Jeffrey P. Kahn & Anna C. Mastroianni - 2018 - American Journal of Bioethics 18 (12):1-2.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  8.  30
    The Task Force Responds.Baruch Brody, Nancy Dubler, Jeff Blustein, Arthur Caplan, Jeffrey P. Kahn, Nancy Kass, Bernard Lo, Jonathan Moreno, Jeremy Sugarman & Laurie Zoloth - 2002 - Hastings Center Report 32 (3):22-23.
  9.  51
    Pharmacogenetics: Ethical Issues and Policy Options.Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody - 2002 - Kennedy Institute of Ethics Journal 12 (1):1-15.
    : Pharmacogenetics offers the prospect of an era of safer and more effective drugs, as well as more individualized use of drug therapies. Before the benefits of pharmacogenetics can be realized, the ethical issues that arise in research and clinical application of pharmacogenetic technologies must be addressed. The ethical issues raised by pharmacogenetics can be addressed under six headings: regulatory oversight, confidentiality and privacy, informed consent, availability of drugs, access, and clinicians' changing responsibilities in the era of pharmacogenetic medicine. We (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  10.  21
    CONCEPTION to Obtain Hematopoietic Stem Cells.John A. Robertson, Jeffrey P. Kahn & John E. Wagner - 2002 - Hastings Center Report 32 (3):34-40.
  11.  24
    Lessons Learned: Challenges in Applying Current Constraints on Research on Chimpanzees to Other Animals.Jeffrey Kahn - 2014 - Theoretical Medicine and Bioethics 35 (2):97-104.
    The Institute of Medicine (IOM) Committee on the Necessity of the Use of Chimpanzees in Biomedical and Behavioral Research made a series of recommendations that, as of an announcement on June 26, 2013, the National Institutes of Health (NIH) is turning into implemented guidelines. Many advocates, including some researchers and scholars, have suggested that the Committee’s recommendations could be applied successfully to other animal species. This article examines, from my perspective as the IOM Committee’s chair, some of the most important (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  12.  31
    Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits.Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner - 2003 - Journal of Law, Medicine and Ethics 31 (3):327-339.
    Successful preimplantation genetic diagnosis to avoid creating a child affected by a genetically-based disorder was reported in 1989. Since then PGD has been used to biopsy and analyze embryos created through in viuo fertilization to avoid transferring to the mother’s uterus an embryo affected by a mutation or chromosomal abnormality associated with serious illness. PGD to avoid serious and early-onset illness in the child-to-be is widely accepted. PGD prevents gestation of an affected embryo and reduces the chance that the parents (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  13.  9
    Swinging on the Pendulum: Shifting Views of Justice in Human Subjects Research.Anna Mastroianni & Jeffrey Kahn - 2001 - Hastings Center Report 31 (3):22-24.
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  14.  60
    Creating a Stem Cell Donor: A Case Study in Reproductive Genetics.Jeffrey P. Kahn & Anna C. Mastroianni - 2004 - Kennedy Institute of Ethics Journal 14 (1):81-96.
    : During the nearly 10 years since its introduction, preimplantation genetic diagnosis (PGD) has been used predominantly to avoid giving birth to a child with identified genetic disease. Recently, PGD was used by a couple not only to test IVF-created embryos for genetic disease, but also to test for a nondisease trait related to immune compatibility with a child in the family in need of an hematopoetic stem cell transplant. This article describes the case, raises some ethical and policy issues, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  15.  63
    Three Views of Organ Procurement Policy: Moving Ahead or Giving Up?Jeffrey P. Kahn - 2003 - Kennedy Institute of Ethics Journal 13 (1):45-50.
    : The supply of organs for transplant remains inadequate to meet the needs of waiting patients, in spite of many programs and approaches to increase rates of donation. Over the years there have been numerous proposals to introduce schemes that would move toward the outright sale of organs. Three articles in this issue of the Journal propose methods for increasing organ supply—two by moving toward a market approach and the third by advocating a change in social culture. All three suffer (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  16.  8
    Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits.Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner - 2003 - Journal of Law, Medicine and Ethics 31 (3):327-339.
    Successful preimplantation genetic diagnosis to avoid creating a child affected by a genetically-based disorder was reported in 1989. Since then PGD has been used to biopsy and analyze embryos created through in viuo fertilization to avoid transferring to the mother’s uterus an embryo affected by a mutation or chromosomal abnormality associated with serious illness. PGD to avoid serious and early-onset illness in the child-to-be is widely accepted. PGD prevents gestation of an affected embryo and reduces the chance that the parents (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  17.  16
    Genetic Testing and the Future of Disability Insurance: Ethics, Law & Policy.Susan M. Wolf & Jeffrey P. Kahn - 2007 - Journal of Law, Medicine and Ethics 35 (s2):6-32.
    Predictive genetic testing poses fundamental questions for disability insurance, a crucial resource funding basic needs when disability prevents income from work. This article, from an NIH-funded project, presents the first indepth analysis of the challenging issues: Should disability insurers be permitted to consider genetics and exclude predicted disability? May disabilities with a recognized genetic basis be excluded from coverage as pre-existing conditions? How can we assure that private insurers writing individual and group policies, employers, and public insurers deal competently and (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  18.  9
    Genetic Harm: Bitten by the Body That Keeps You?Jeffrey P. Kahn - 1991 - Bioethics 5 (4):289–308.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  19.  32
    American College of Epidemiology Ethics Guidelines: Foundations and Dissemination.Robert E. McKeown, Douglas L. Weed, Jeffrey P. Kahn & Michael A. Stoto - 2003 - Science and Engineering Ethics 9 (2):207-214.
    Epidemiology is a core science of public health, focusing on research related to the distribution and determinants of both positive and adverse health states and events and on application of knowledge gained to improve public health. The American College of Epidemiology (ACE) is a professional organization devoted to the professional practice of epidemiology. As part of that commitment, and in response to concerns for more explicit attention to core values and duties of epidemiologists in light of emerging issues and increased (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  20.  33
    Bioethics Matures: The Field Faces the Future.Susan M. Wolf & Jeffrey P. Kahn - 2005 - Hastings Center Report 35 (4):22-24.
  21.  3
    Genetic Testing and the Future of Disability Insurance: Ethics, Law & Policy.Susan M. Wolf & Jeffrey P. Kahn - 2007 - Journal of Law, Medicine and Ethics 35 (S2):6-32.
    Genetic testing poses fundamental questions for insurance. Testing can predict a low probability of future illness and disability, which can help promote the insurability of individuals with a family history of genetic risk, but it can also invite insurers to reject applicants, increase premiums, exclude people with certain illnesses and disabilities, and otherwise adjust the underwriting processes for individuals with certain genotypes. In the workplace, these issues may cause employers who offer or pay for insurance to alter their hiring behavior, (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  22.  11
    What Happens When Politics Discovers Bioethics?Jeffrey P. Kahn - 2006 - Hastings Center Report 36 (3):10-10.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  23.  1
    Clinical, Ethical, and Legal Issues in Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor.Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner - 2003 - Journal of Law, Medicine and Ethics 31 (3):327-39.
    Successful preimplantation genetic diagnosis to avoid creating a child affected by a genetically-based disorder was reported in 1989. Since then PGD has been used to biopsy and analyze embryos created through in viuo fertilization to avoid transferring to the mother’s uterus an embryo affected by a mutation or chromosomal abnormality associated with serious illness. PGD to avoid serious and early-onset illness in the child-to-be is widely accepted. PGD prevents gestation of an affected embryo and reduces the chance that the parents (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  24.  5
    Making the Most of Strangers' Altruism.Jeffrey Kahn - 2002 - Journal of Law, Medicine and Ethics 30 (3):446-447.
    Lainie Ross, in her article in this issue, criticizes on ethical grounds a number of factors in the University of Minnesota program that allows unrelated strangers to donate kidneys for transplant. I have to admit that when the transplant center at the University proposed allowing the practice of what came to be called nondirected donation, I was skeptical about a number of the same issues that trouble Dr. Ross. But as my colleagues and I examined and discussed the ethics of (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  25.  12
    The Implications of Public Health for Bioethics.Jeffrey Kahn & Anna Mastroianni - 2009 - In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. Oxford University Press.
    At its core, public health introduces tensions between individuals' autonomy and the need to account for the perspectives and needs of communities and populations. It further raises social justice issues, including fair allocation of limited resources. This article examines and elaborates on these tensions and their resolutions using specific public health examples. Experiences in the 1980s and 1990s with HIV/AIDS provide a particularly rich collection of issues that brought ethical issues in public health to the public's attention, and in so (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  26.  11
    Looking Forward in Bioethics.Jeffrey Kahn & Anna Mastroianni - 2004 - Journal of Law, Medicine and Ethics 32 (2):196-197.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  27.  14
    Docs on the Box Or, How We Learned to Stop Worrying and Love the Tube.Carl Elliott & Jeffrey Kahn - 1994 - Hastings Center Report 24 (6):22-23.
  28.  17
    Can We Broker Eggs Without Making Omelets?Jeffrey Kahn - 2001 - American Journal of Bioethics 1 (4):14 – 15.
  29.  6
    It's a Small World After All: Ethics and the Response to SARS.Jeffrey Kahn - 2003 - Hastings Center Report 33 (3):6-6.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  30.  4
    Looking Forward in Bioethics.Jeffrey Kahn & Anna Mastroianni - 2004 - Journal of Law, Medicine and Ethics 32 (2):196-197.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  31.  2
    Genetic Harm: Bitten by the Body That Keeps You?Jeffrey P. Kahn - 1991 - Bioethics 5 (4):289-308.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  32. Cross-Cultural Biotechnology: A Reader.Stella Gonzalez Arnal, Donald Chalmers, David Kum-Wah Chan, Margaret Coffey, Jo Ann T. Croom, Mylène Deschênes, Henrich Ganthaler, Yuri Gariev, Ryuichi Ida, Jeffrey P. Kahn, Martin O. Makinde, Anna C. Mastroianni, Katharine R. Meacham, Bushra Mirza, Michael J. Morgan, Dianne Nicol, Edward Reichman, Susan E. Wallace & Larissa P. Zhiganova (eds.) - 2004 - Rowman & Littlefield Publishers.
    This book is a rich blend of analyses by leading experts from various cultures and disciplines. A compact introduction to a complex field, it illustrates biotechnology's profound impact upon the environment and society. Moreover, it underscores the vital relevance of cultural values. This book empowers readers to more critically assess biotechnology's value and effectiveness within both specific cultural and global contexts.
     
    Export citation  
     
    Bookmark   1 citation  
  33.  19
    By Author BAGHERI, Alireza. Criticism of “Brain.Tom L. Beauchamp, Howard Brody, Franklin G. Miller, Alexander S. Curtis, Martina Darragh, Patricia Milmoe, Ronald M. U. S. Green, Sharona Hoffman, Edmund G. Howe & Jeffrey P. Kahn - 2003 - Kennedy Institute of Ethics Journal 13 (4):407-09.
  34.  1
    Toward Justice in Human Subjects ResearchBeyond Consent: Seeking Justice in Research.Lisa Sowle Cahill, Jeffrey P. Kahn, Anna C. Mastroianni & Jeremy Sugarman - 2000 - Hastings Center Report 30 (4):45.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  35.  9
    Introduction.P. Kahn Jeffrey & C. Mastroianni Anna - 1996 - Kennedy Institute of Ethics Journal 6 (3):ix-xi.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  36. A Multi-Faceted HistoryUseful Bodies: Humans in the Service of Medical Science in the Twentieth Century.Jeffrey Kahn, Jordan Goodman, Anthony McElligott & Laura Marks - 2005 - IRB: Ethics & Human Research 27 (5):19.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  37.  2
    An Unprotected Public.Jeffrey Kahn - 2008 - American Journal of Bioethics 8 (6):3 – 4.
  38.  9
    Baseball, Alcohol and Public Health.Jeffrey P. Kahn - 2007 - American Journal of Bioethics 7 (7):3.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  39. Beyond Consent: Seeking Justice in Research.Jeffrey P. Kahn, Anna C. Mastroianni & Jeremy Sugarman (eds.) - 1998 - Oup Usa.
    Beyond Consent examines the concept of justice, and its application to human subject research, through the different lenses of various research populations: children, the vulnerable sick, captive and convenient populations, women, people of colour, and subjects in international settings. Separate chapters address the evolution of research policies, implications of the concept of justice for the future of human subject research, and the ramifications of this concept throughout the research enterprise.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   13 citations  
  40.  10
    Commentary on Zohar's "Prospects for‘Genetic Therapy’- Can a Person Benefit From Being Altered?".Jeffrey P. Kahn - 1991 - Bioethics 5 (4):312–317.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  41.  2
    Commentary on Zohar's “Prospects for‘Genetic Therapy’‐ Can a Person Benefit From Being Altered?”.Jeffrey P. Kahn - 1991 - Bioethics 5 (4):312-317.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  42.  4
    Commentary: Who's Afraid of the RAC? Lessons From the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
    This commentary asks what we can learn from our oversight of controversial science and how can we do better in the future? After briefly examining the history of gene transfer research oversight, some observations are offered for the oversight of nanobiotechnology and other emerging areas of science.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  43.  1
    Commentary: Who's Afraid of the RAC? Lessons From the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
    No categories
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  44.  10
    Genetic Counselors' Impact on the Genetics Revolution: Recommendations of an Informed Outsider.Jeffrey Kahn - 2004 - Bioethics Examiner 8.
  45.  2
    Letter to the Editor.Jeffrey P. Kahn - 2005 - American Journal of Bioethics 5 (3):W13-W13.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  46.  24
    Organs and Stem Cells: Policy Lessons and Cautionary Tales.Jeffrey P. Kahn - 2007 - Hastings Center Report 37 (2):11-12.
  47.  6
    Raising the Bar: The Implications of the IOM Report on the Use of Chimpanzees in Research.Jeffrey Kahn - 2012 - Hastings Center Report 42 (s1):S27 - S30.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  48.  4
    Understanding the Role of Genetics in Disability Insurance.Jeffrey P. Kahn & Susan M. Wolf - 2007 - Journal of Law, Medicine and Ethics 35 (s2):5-5.
  49.  1
    Understanding the Role of Genetics in Disability Insurance.Jeffrey P. Kahn & Susan M. Wolf - 2007 - Journal of Law, Medicine and Ethics 35 (S2):5-5.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  50.  4
    Why Public Health and Politics Don't Mix.Jeffrey P. Kahn - 2007 - American Journal of Bioethics 7 (11):3 – 4.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
1 — 50 / 55